Ashvinikumar V Gavai

6PUBLICATIONS
20CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biomolecular modelling and designCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer.

|Jan 15, 2025
Structure-Based Design of Novel TLR7/8 Agonist Payloads Enabling an Immunomodulatory Conjugate Approach.

Yam B Poudel, Julian C Lo, Derek J Norris

|Oct 22, 2024
Discovery and Synthesis of Heterobifunctional Degraders of Rearranged during Transfection (RET) Kinase.

Jennifer X Qiao, David Williams, Patrice Gill

|Feb 14, 2024
Identification and Optimization of Small Molecule Pyrazolopyrimidine TLR7 Agonists for Applications in Immuno-oncology.

Liqi He, Meng Yao Zhang, Matthew Cox

|Feb 14, 2024
Discovery of Novel TLR7 Agonists as Systemic Agent for Combination With aPD1 for Use in Immuno-oncology.

Yam B Poudel, Liqi He, Matthew Cox

|Sep 20, 2021
Discovery and Preclinical Pharmacology of an Oral Bromodomain and Extra-Terminal (BET) Inhibitor Using Scaffold-Hopping and Structure-Guided Drug Design.

Ashvinikumar V Gavai, Derek Norris, George Delucca

Pageof 1

Frequent Collaborators

4 joint publications

Murugaiah A M Subbaiah

3 joint publications

Yam B Poudel

3 joint publications

Prasanna Sivaprakasam

2 joint publications

Martins S Oderinde